GSK plc reported that three executives acquired American Depositary Shares (ADSs) on July 17, 2025, using dividends reinvested from July 10, 2025, at a price of $38.1181 per share, totaling 4,492.051 ADSs. The executives involved are Dr. Hal Barron, James Ford, and Shobie Ramakrishnan.